Furthermore, the use of anti‐CSF1/CSF1R agents has demonstrated synergistic effects with ADT in managing PCa by reducing pro‐tumor CAM infiltration both in vitro and in vivo. Here, CSF1R is linked to posterior cortical atrophy.